Three cell lines were utilized in this study [human hepatocellular cancer cell line (HepG-2) cells, human leukemia cancer cell line (K-562) cells, and normal human lung fibroblast cells (MRC-5)] and all were acquired from the American Type Culture Collection (ATCC, Rockville, MD). HepG-2 and K-562 cells were grown in Rosewell Park Memorial institute medium (RPMI-1640) (Sigma Aldrich, USA) supplemented with 50 µg/ml gentamycin and 10% inactivated fetal calf serum. The cells were kept at 37ºC in a humidified atmosphere with 5% CO2 and were sub-cultured two to three times a week (Cruz et al. 2020; dos Santos et al. 2020). On the other hand, MRC-5 cells were propagated in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma Aldrich, USA) containing 10% heat-inactivated fetal bovine serum, HEPES buffer (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 1% L-glutamine, and 50 µg/ml gentamycin. All cells were kept at 37ºC in a humidified atmosphere with 5% CO2 and were sub-cultured two times a week (Hall et al. 2021).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.